ReCode Therapeutics Competitors and Similar CompaniesClear all

ReCode Therapeutics's competitors and similar companies include Synspira, Verona Pharma and PTC Therapeutics.

	ReCode Therapeutics ReCode Therapeutics is a company developing non-viral nanoparticles for delivery of diverse RNA- and protein-based therapeutics to targeted tissues, and tRNA NanoCorrectors.	Synspira Synspira Therapeutics is a company providing treatment for people with cystic fibrosis and other rare diseases.	Verona Pharma Verona Pharma is a biotechnology company dedicated to discovering new drugs for the treatment of chronic respiratory diseases.	PTC Therapeutics PTC Therapeutics is a biopharmaceutical company that engages in the discovery, development, and commercialization of small-molecule drugs.
Founding Date	Founding Date 2015	Founding Date 2017	Founding Date N/A	Founding Date 1998
Type	Type Private	Type Private	Type Public	Type Public
Tags	Tags Healthcare bioengineering biotech genetics nanotech pharma	Tags Healthcare biotech drug development therapy	Tags Healthcare biotech pharma	Tags Healthcare biotech drug development pharma
Locations	Locations Menlo Park, US HQ	Locations Framingham, US HQ	Locations London, GB HQ Cardiff, GB Raleigh, US	Locations South Plainfield, US HQ
Employees	Employees 1062% decrease	Employees 6	Employees 79	Employees 75448% increase
Valuation ($)	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) 2.7 b	Valuation ($) 3.3 b
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) $42.3m (FY, 2024)	Revenue (est.) $1.7b (FY, 2025)
Net income	Net income N/A	Net income N/A	Net income ($173.2m) (FY, 2024)	Net income $682.6m (FY, 2025)
Funding
Latest funding round	Latest funding round $ 80m (over 6 years ago)	Latest funding round $ 3m (over 8 years ago)	Latest funding round N/A	Latest funding round N/A
Total funding raised	Total funding raised $ 82m	Total funding raised $ 11.2m	Total funding raised $ 11.5m	Total funding raised N/A